| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | 1,899,251 | 1,226,954 | ||
| General and administrative | 1,576,577 | 1,540,910 | ||
| Total operating expenses | 3,475,828 | 2,767,864 | ||
| Loss from operations | -3,475,828 | -2,767,864 | ||
| Investment income, net | 46,704 | 27,305 | ||
| Total other income, net | 46,704 | 27,305 | ||
| Net loss | -3,429,124 | -2,740,559 | ||
| Basic | -1.16 | -2.15 | ||
| Basic | 2,943,655 | 1,277,217 | ||
| Diluted | -1.16 | -2.15 | ||
| Diluted | 2,943,655 | 1,277,217 | ||
Imunon, Inc. (IMNN)
Imunon, Inc. (IMNN)